Whats cracking?
Turns out it’s Krakatoa!
Krakatoa Resources (ASX:KTA)
If an absolute eruption of price hasn’t quite hit yet for critical minerals hunting junior Krakatoa, a boom of activity is certainly taking place. It’ll definitely take the simmering +26% price action this afternoon, however.
• The $10.4m market-capped company has begun a reverse circulation (RC) drill program to test high-grade lithium targets at King Tamba.
• Grades of up to 4.3% Li from rock chip samples are being targeted.
• Drilling will be conducted across the Wilsons, Loader and MGM prospects…
• … with 12-15 RC holes, spanning 1,200 metres, to be drilled as part of the campaign.
• All three prospects have previously returned high-grade lithium results.
Across Markets…
- ASX ended the month of October more than 3pc lower
- RBA warns that social media could lead to SVB-style collapse in Australia
- The US Fed will convene for the first of its two-day meeting tonight
Local shares ended the last trading day of October flattish despite opening higher this morning. For the month, the benchmark ASX 200 index was down over -3.5%.
Today’s session began with a speech by Brad Jones, an assistant RBA governor, who told a press conference that the “emerging risks we are likely to confront over the next decade have a different complexion to those of recent decades”.
Jones listed risks we are likely to face such as sudden withdrawal of deposits sparked by social media, citing the demise of California-based Silicon Valley Bank earlier this year.
Many traders stayed on the sidelines as they await the result of the US Fed meeting, which will convene later tonight, with a rates decision announced on Thursday AEDT.
“The Fed will not raise rates this week, as there is no need to exercise that option just yet and the markets are not demanding further tightening,” said Erik Weisman, Chief Economist and Portfolio Manager at MFS Investment Management.
“But, until the labour market has cooled considerably, and inflationary pressures display sufficiently persistent containment, the Fed will keep the option of future rate hikes firmly on the table.”
On the ASX, a tsunami of companies (both large and small caps) lodged their September quarter reports today, being the last day of the month.
Gains in the Staples and Real Estate sectors were offset by losses in Mining and Energy sectors. Most energy stocks fell after a 3% slump in crude prices overnight.
Best large cap today was food company Inghams Group (ASX:ING), which rose 7% (see more details below).
Lithium stocks like Pilbara (ASX:PLS) and Mineral Resources (ASX:MIN) were the worst performers.
Treasury Wine Estates (ASX:TWE) is in a trading halt, pending an announcement on a potential acquisition of high-end Californian wine group Daou Vineyards for $US1 billion.
Source: Stockhead
Cell therapy development company Chimeric Therapeutics (ASX: CHM) has received confirmation that the US Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for its lead candidate CHM 2101 to treat gastrointestinal cancers.
The first-in-class CDH17 CAR T cell therapy will now be subject to a multi-centre, open label Phase 1A/B clinical trial for patients with advanced colorectal, gastric and neuroendocrine tumours.
The company plans to begin patient enrolments in the new year.
Third-generation solution
CHM 2101 is a third-generation solution developed to target the CDH17 (Cadherin-17) biomarker which is associated with poor prognosis and metastasis in the most common gastrointestinal carcinomas.
Research has shown that overall survival rates in patients with CDH17 upregulation are lower than in those without expression of the gene.
The clinical program for CHM 2101 builds on pre-clinical studies which demonstrated the eradication of established tumours in seven cancer models with no toxicity to normal tissues.
It is believed to be a critical step forward in developing a new CAR T therapy for gastric cancers and may provide new hope for patients who are refractory to existing therapies.
CHM 2101 has been labelled a “potentially transformative new investigational agent” in cancer care.
Source: Small Caps
Sector: Lithium
Deal Type: Placement
Raise Amount: $1.75M
Latest Entry Price: $0.006 with a 1:2 AL8OA
Today’s Price Change: $0.012 Unchanged
Company: Terra Uranium (ASX:T92)
Sector: Uranium
Deal Type: IPO
Raise Amount: $7.5M
Latest Entry Price: $0.20
Today’s Price Change: $0.13 Unchanged
Company: Patagonia Lithium (ASX:PL3)
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.20
Today’s Price Change: $0.12 Unchanged
Company: Gold Mountain Limited (ASX:GMN)
Sector: Lithium
Deal Type: Placement
Raise Amount: $2.25M
Latest Entry Price: $0.0075
Today’s Price Change: $0.005 -16.67%
Company: Unith Ltd. (ASX:UNT)
Sector: AI/ChatGPT
Deal Type: Placement
Raise Amount: $4.5M
Latest Entry Price: $0.033 with a 1:1 UNTO
Today’s Price Change: $0.0200 -4.76%
Company: Volt Resources Ltd. (ASX:VRC)
Sector: Battery Metals
Deal Type: Placement
Raise Amount: $5.75M
Latest Entry Price: $0.011
Today’s Price Change: $0.007 Unchanged
Company: Castle Minerals Ltd. (ASX:CDT)
Sector: Battery Metals/Base Metals
Deal Type: Placement
Raise Amount: $1.52M
Latest Entry Price: $0.02 with a 2:3 CDTOA
Today’s Price Change: $0.01 Unchanged
Company: Avenira Ltd. (ASX:AEV)
Sector: Phosphate
Deal Type: Placement
Raise Amount: $2.1M
Latest Entry Price: $0.01 with a 1:2 AEVO
Today’s Price Change: $0.012 -7.69%
Company: Latrobe Magnesium Ltd. (ASX:LMG)
Sector: Magnesium
Deal Type: Placement
Raise Amount: $3M & $11.5M
Latest Entry Price: $0.10 with a 1:4 LMGO
Today’s Price Change: $0.047 +6.82%
Company: Askari Metals Ltd (ASX:AS2)
Sector: Mining
Deal Type: IPO
Raise Amount: $5.7M
Latest Entry Price: $0.35 with a 1:3 AS2O
Today’s Price Change: $0.16 +3.23%
Company: iCandy (ASX:ICI)
Sector: Gaming & Digital Advertising
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.02 with a 1:1 ICIOB
Today’s Price Change: $0.033 +22.22%
Sector: Fintech
Deal Type: Placement
Raise Amount: $1.5M
Latest Entry Price: $0.015 with a 1:2 FFGOA
Today’s Price Change: $0.011 Unchanged
Company: Paradigm Biopharma (ASX:PAR)
Sector: Biopharma
Deal Type: IPO Cornerstone
Raise Amount: $1M+
Latest Entry Price: $0.35
Today’s Price Change: $0.62 Unchanged
Company: ReNu Energy Limited (ASX:RNE)
Sector: Energy
Deal Type: Placement
Raise Amount: $1.46M
Latest Entry Price: $0.06 with a 1:1 RNEO
Today’s Price Change: $0.020 -13.04%
Company: Carly Holdings Ltd (ASX:CL8)
Sector: AI and Car subscription
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.025 with a 1:2 CL8O
Today’s Price Change: $0.015 Unchanged
Sector: CBD
Raise Amount: $5M
Latest Entry Price: $0.006 with a 3:2 AVEOA
Today’s Price Change: $0.004 Unchanged
Sector: Medicinal Cannabis
Deal Type: Placement
Raise Amount: $6.6M
Latest Entry Price: $0.033 with 1:2 ECSO
Today’s Price Change: $0.023 Unchanged
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
No responses yet